A study published in the journal Science and coordinated by researchers of IDIBAPS and the UB describes a new immune defence mechanism unknown until1
An AI model based on information from more than three thousand clinical reports generated by the Hospital Clínic during the acute phase of the pandem1
Researchers of IDIBAPS have participated in an interdisciplinary research study of the UB in which there have been identified two potential candidate1
Researchers from the Respiratory biophysics and bioengineering IDIBAPS research group, the Biophysics and Bioengineering Unit of the UB and the CIBER1
Uveitis is a disease that causes inflammation of the tissues inside the eye. More specifically, non-infectious uveitis (NIU) causes 20% of cases of b1
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publis1
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
A study coordinated by researchers of the Clínic-IDIBAPS and published in The Lancet Gastroenterology & Hepatology establishes the safe dose of simva1
Researchers from the IDIBAPS and the Institute of Neurosciences of the University of Barcelona (UBNeuro) described a mechanism, the increase of prote1
